# IGC Pharma, Inc.: Form 8-K, filed Feb 29, 2016

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2016-02-29
- Accepted by EDGAR: Feb 29, 2016, 17:00 ET
- Period: 2016-02-24
- Accession: 0001185185-16-003794
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518516003794/indiaglobalization8k022616_2.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518516003794/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518516003794/indiaglobalization8k022616_2.htm

Filed Feb 29, 2016.
Source: SEC EDGAR, the filing index for accession 0001185185-16-003794. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
